Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-10-12FDA Approved: MOMETASONE FUROATE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for mometasone furoate.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for lebikizumab in participants with persistent moderate to severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating safety and bioequivalence of pimecrolimus 1% cream vs Elidel R for mild to moderate atopic dermatitis; study comple…
-
FDA approval · 2017-09-22FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for clobetasol propionate as a generic topical corticosteroid.
-
FDA approval · 2017-09-19FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)
FDA approved Desoximetasone from Viona Pharmaceuticals Inc via an Original Application (ANDA205206).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis. [NA]
Completed clinical trial update from AOBiome LLC evaluating a cosmetic treatment to improve the appearance of skin in mild-to-moderate atopi…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 trial of dupilumab in adults with moderate-to-severe atopic dermatitis completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores [NA]
A completed Columbia University-sponsored clinical trial evaluating whether a text messaging intervention can optimize learning and improve …
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: In-Use Test With a Cosmetic Product [NA]
A completed clinical trial update describes an in-use test of a cosmetic product for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Multi-Center Study Evaluating the Safety of AC-170 0.24% [Phase 3]
A Phase 3 trial evaluating the safety of AC-170 0.24% in atopic disease including allergic conjunctivitis has completed with results posted …
-
FDA approval · 2017-07-21FDA Approved: FLUOCINONIDE — Original Application (Novel Laboratories, Inc.)
FDA approval for fluocinonide from Novel Laboratories, Inc. as an Original Application (ANDA), representing first-time approval of this gene…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Study Assessing GW870086's Potential to Cause Skin Thinning [Phase 1]
This Phase 1 study evaluated whether GW870086 could cause skin thinning in individuals with atopic dermatitis. The trial has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Skin Irritation Study of GSK2894512 Cream [Phase 1]
Phase 1 skin irritation study of GSK2894512 cream has completed; study sponsor was GlaxoSmithKline.
-
FDA approval · 2017-07-17FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's generic fluocinonide acetonide as an original application (ANDA 202849) for topical tr…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis [Phase 2]
Phase 2 open-label trial evaluating whether early skin barrier protection can reduce the development of atopic dermatitis; the study has com…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: VANOS Cream and Skin Barrier Function [Phase 4]
Phase 4 clinical trial investigating VANOS Cream and its effect on skin barrier function in people with Atopic Dermatitis; the study has com…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World
A real-world registry study is evaluating Runzaozhiyang Capsule for eczema, sponsored by the China Academy of Chinese Medical Sciences.
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of tralokinumab in adults with atopic dermatitis has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit [Phase 4]
This Phase 4 clinical trial update from Wake Forest University assesses how well children with atopic dermatitis adhere to topical therapy a…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients [Phase 2]
Phase 2 trial update reporting efficacy, safety, and dose-finding outcomes for topical Jaungo in atopic dermatitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis [NA]
A completed clinical trial evaluating the effects of diluted sodium hypochlorite solution, with moisturizers, on skin barrier function in pe…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis [NA]
A completed clinical trial sponsored by University of California, Davis compared asynchronous online care with usual in-office care for mana…
-
FDA approval · 2017-05-26FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for betamethasone dipropionate from Sun Pharmaceutical Industries, Inc., authorizing an update to th…
-
FDA approval · 2017-05-24FDA Approved: BETAMETHASONE VALERATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original generic application for Betamethasone valerate. This approval makes the generic …
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children [NA]
Clinical trials.gov reports completion of a study evaluating a new device for safety and efficacy in managing mild-to-moderate atopic dermat…